Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 12:52 AM ET

Healthcare Providers and Services

Company Overview of Fresenius Medical Care Holdings Inc.

Company Overview

Fresenius Medical Care Holdings Inc., doing business as Fresenius Medical Care North America, provides kidney dialysis and renal services in North America. It manufactures and distributes various dialysis equipment, including dialysis machines and disposables, dialyzers, bloodlines, and concentrates, as well as renal pharmaceuticals. The company also provides home therapies services, such as peritoneal dialysis and home hemodialysis services; and patient care, vascular care, and pharmacy services. In addition, it offers laboratory products and services in the renal industry; inpatient dialysis treatment services; and dialysis treatment therapies, therapeutic apheresis therapies, and quality ...

920 Winter Street

Waltham, MA 02451-1457

United States

60,625 Employees

Phone:

781-402-9000

Fax:

781-402-9005

Key Executives for Fresenius Medical Care Holdings Inc.

Chief Executive Officer
Age: 55
Chief Financial Officer
Senior Vice President of Operations and President of West Division
Deputy Chairman of The Management Board and Chief Executive Officer of Fresenius Medical Care North America
Age: 59
Chief Executive Officer of Extracorporeal Alliance
Age: 68
Compensation as of Fiscal Year 2015.

Fresenius Medical Care Holdings Inc. Key Developments

Fresenius Medical Care’s Patient Engagement May Have Saved Lives During Superstorm Sandy

Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care hailed a new study by the Department of Health and Human Services (HHS) this week showing that dialysis patients who received treatments immediately before Super Storm Sandy experienced a much better survival rate and less frequent visits to the hospital. FMCNA provided pre-storm, weekend care to a wide section of the area surveyed by the study, indicating that the company’s efforts made an appreciable difference in patients’ lives. The HHS study based on 13,836 patients who received dialysis across the State of New Jersey and New York City found that receiving early dialysis reduced the chances of needing emergency room care or hospitalization by 20% and 21%, respectively. Most importantly, patients who received early treatment showed a 28% lower chance of death 30 days after the storm.

Fresenius Medical Care Holdings Inc. Wins $1,046,013.12 Federal Contract

Fresenius Medical Care Holdings Inc., Waltham, Massachusetts, won a $1,046,013.12 federal contract from the U.S. Department of Veterans Affairs' Hampton Medical Center, Hampton, Virginia, for inpatient dialysis services.

Fresenius Medical Care North America Announces Voluntary Recall of 56 Lots of NaturaLyte(R) Liquid Bicarbonate Concentrate

Fresenius Medical Care North America announced that its voluntary recall of 56 lots of NaturaLyte(R) Liquid Bicarbonate Concentrate, 6.4 liters (intended for use in hemodialysis machines) from distribution has been classified as a Class 1 Recall. The affected lots were produced in its Montreal, Canada facility and are being recalled because they may develop higher bacteria levels than is allowed by the company's internal specification during their shelf life. Laboratory testing has identified the bacteria as Halomonas (species 1, 2, 3), a Gram Negative bacteria, typically found in water with high salinity (salt concentration). According to a few case reports in the medical literature, bacterial contamination of the dialysate may lead to bacteremia or systemic infection. The dialysis filter (dialyzer) and the use of the Diasafe(TM) filter or equivalent create an effective bacteria and endotoxin barrier that makes this event unlikely.

Similar Private Companies By Industry

Company Name Region
Heritage Healthcare, Inc. United States
American Medical Pharmaceutical Outlet United States
MedSolutions Holdings Inc. United States
Extendicare Health Center United States
Pacific Endoscopy and Surgery Center, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
August 4, 2015
--
Private Placement
July 30, 2015
--
Private Placement
June 19, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fresenius Medical Care Holdings Inc., please visit www.fmcna.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.